Table 1.
Event |
Admission |
Conventional surgical and radiation therapies |
Burosumab initiation |
Normal range |
|||
---|---|---|---|---|---|---|---|
Entire follow-up period | X − 15 years | X − 10 years | X − 5 years | X year | X + 4 months | X + 6 months | |
BGP (ng/mL) | 7.6 | 4.1 | 3.3 | 4.8 | 12.3 | 11.6 | 8.4–33.1 |
BAP (μg/L) | 34.7 | 14.2 | 14.7 | 10.4 | – | 9.9 | 3.7–20.9 |